SCHEMBL19356146

SCHEMBL19356146

C/C=C(\CN)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22820870 0.77 ALDH1A1 (0.30) —
SCHEMBL20989251 0.76 GRIK1 (0.33) —
SCHEMBL13755853 0.73 — —
SCHEMBL21505776 0.73 — —
SCHEMBL2509174 0.73 — —
SCHEMBL8931299 0.71 — —
SCHEMBL19177004 0.71 — —
SCHEMBL28187556 0.69 — —
SCHEMBL18411693 0.69 — —
SCHEMBL20216144 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247984-B2 Uracil containing compounds CV6 THERAPEUTICS (NI) LIMITED (GB) 2022-02-15 — — US disclosed
US-20200039966-A1 URACIL CONTAINING COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-02-06 — — US disclosed
WO-2017156074-A1 CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF BLADE THERAPEUTICS, INC. (US) 2017-09-14 — — WO disclosed
Send feedback